Journals / Turkish Journal of Hematology / 2020 / Cilt: 37 - Sayı: 4

Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura

Pages
302–304
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ARIKAN, F., YILDIZ, Y., ERCAN, T., ORUÇ, Ö., AKÇAY, S., YILMAZ, F., TOPTAŞ, T., TUĞLULAR, T. (2020). Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura. Turkish Journal of Hematology, Cilt: 37 - Sayı: 4, 302–304. https://ajindex.com/articles/411710

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Bendapudi PK, Hurwitz S, Fry A, Marques MB, Waldo SW, Li A, Sun L, Upadhyay V, Hamdan A, Brunner AM, Gansner JM, Viswanathan S, Kaufman RM, Uhl L, Stowell CP, Dzik WH, Makar RS. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol 2017;4:e157-e164
  2. George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood 2010;116:4060-4069
  3. Fromm LM. Suspected hydroxychloroquine-induced thrombotic thrombocytopaenic purpura. J Pharm Pract Res 2018;48:72-75
  4. Mar N, Mendoza Ladd A. Acquired thrombotic thrombocytopenic purpura: puzzles, curiosities and conundrums. J Thromb Thrombolysis 2011;31:119-121
  5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245.